NLRP3 inflammasome
The purinergic p2x7 receptor-nlrp3 inflammasome pathway: A new target in alcoholic liver disease?
14
Double-walled carbon nanotubes trigger IL-1β release in human monocytes through Nlrp3 inflammasome activation
11
Double-walled carbon nanotubes trigger IL-1β release in human monocytes through Nlrp3 inflammasome activation
10
Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation
19
The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine.
16
en fr Involvement of purinergic receptors in NLRP3-inflammasome pathway from macrophages Implication des récepteurs purinergiques dans l'activation de l'inflammasome NLRP3 dans les macrophages
195
Protein kinase D at the Golgi controls NLRP3 inflammasome activation
24
S100A8 and S100A9 Induce Cytokine Expression and Regulate the NLRP3 Inflammasome via ROS-Dependent Activation of NF-kappaB(1.)
12
NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases
13
en fr The ambivalent action of the anti-cancer agent 5-Fluorouracil on myeloid derived suppressor cells under control of docosahexaenoic acid : Role of NLRP3 inflammasome and the JNK pathway in the secretion of IL-1beta L'action ambivalente de l'agent anti-cancéreux 5-Fluorouracile sur les cellules myéloïdes immunosuppressives sous contrôle de l'acide docosahexaénoïque : Rôle de l'inflammasome NLRP3 et de la voie JNK dans la sécrétion de l'IL-1beta
254
en fr L’inflammasome NLRP3 : physiopathologie et application thérapeutique [The NLRP3 inflammasome: Physiopathology and therapeutic application] L’inflammasome NLRP3 : physiopathologie et application thérapeutique
23
Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages
11
The mitochondrial protease HtrA2 restricts the NLRP3 and AIM2 inflammasomes
11
Targeting TMEM176B Enhances Antitumor Immunity and Augments the Efficacy of Immune Checkpoint Blockers by Unleashing Inflammasome Activation
23
en fr Study of NLRP3 in MDSC and CD4+ T cells in cancer Etude de NLRP3 dans les cellules myéloïdes immunosuppressives et les lymphocytes TCD4 dans un contexte de cancer
208
NLRP3 controls ATM activation in response to DNA damage
45
The release of pro-inflammatory cytokines is mediated via mitogen-activated protein kinases rather than by the inflammasome signalling pathway in keratinocytes
25
NLRP3, un inflammasome sous contrôle
7
Human Amnion Epithelial Cells (AECs) Respond to the FSL-1 Lipopeptide by Engaging the NLRP7 Inflammasome
13
en fr Role of the inflammasome and of Styk1 kinase in the regulation of cytotoxic lymphocytes Étude du rôle de l’inflammasome et de la kinase Styk1 dans la régulation des lymphocytes cytotoxiques
177